Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, May 2001, p. 1505-1510, Vol. 45, No. 5
Division of Specific Prophylaxis and Tropical
Medicine1 and Division of Applied
Experimental Pathology,2 Department of
Pathophysiology, University of Vienna, A-1090 Vienna, Austria, and
Max-Planck-Institute of Biophysical Chemistry, D-37077
Göttingen, Germany3
Received 1 November 2000/Returned for modification 18 December
2000/Accepted 12 February 2001
The protozoan parasite Entamoeba histolytica is the
cause of amoebic dysentery and liver abscess. It is therefore
responsible for significant morbidity and mortality in a number of
countries. Infections with E. histolytica are treated
with nitroimidazoles, primarily with metronidazole. At this time, there
is a lack of useful alternative classes of substances for the treatment
of invasive amoebiasis. Alkylphosphocholines (alkyl-PCs) such as hexadecyl-PC (miltefosine) were originally developed as antitumor agents, but recently they have been successfully used for the treatment
of visceral leishmaniasis in humans. We examined hexadecyl-PC and
several other alkyl-PCs with longer alkyl chains, with and without
double bond(s), for their activity against two strains of E.
histolytica. The compounds with the highest activity were oleyl-PC, octadecyl-PC, and nonadecenyl-PC, with 50% effective concentrations for 48 h of treatment between 15 and 21 µM for strain SFL-3 and between 73 and 98 µM for strain HM-1:IMSS. We also
tested liposomal formulations of these alkyl-PCs and miltefosine. The
alkyl-PC liposomes showed slightly lower activity, but are expected to
be well tolerated. Liposomal formulations of oleyl-PC or closely
related alkyl-PCs could be promising candidates for testing as
broad-spectrum antiprotozoal and antitumor agents in humans.
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.5.1505-1510.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Effects of Miltefosine and Other
Alkylphosphocholines on Human Intestinal Parasite
Entamoeba histolytica
*
Corresponding author. Mailing address: Division of
Specific Prophylaxis and Tropical Medicine, Department of
Pathophysiology, Vienna General Hospital, Währinger Gürtel
18-20, A-1090 Vienna, Austria. Phone: (43-1) 40400-5108. Fax: (43-1)
40400-5130. E-mail: michael.duchene{at}univie.ac.at.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»